BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7287708)

  • 1. Increased secretion of very low density lipoprotein triglyceride following inhibition of long chain fatty acid oxidation in isolated rat liver.
    Ide T; Ontko JA
    J Biol Chem; 1981 Oct; 256(20):10247-55. PubMed ID: 7287708
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of the oral hypoglycemic agent 2-tetradecylglycidic acid on fatty acid oxidation in suckling rats in vivo and in perfused liver.
    Frost SC; Wells MA
    Arch Biochem Biophys; 1981 Oct; 211(2):547-55. PubMed ID: 7305389
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on carbohydrate and fatty acid metabolism in liver and muscle.
    Schudt C; Simon A
    Biochem Pharmacol; 1984 Nov; 33(21):3357-62. PubMed ID: 6437406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of the oral hypoglycemic agent 2-tetradecylglycidic acid on hepatic fatty acid oxidation and gluconeogenesis.
    Tutwiler GF; Dellevigne P
    J Biol Chem; 1979 Apr; 254(8):2935-41. PubMed ID: 429328
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on intermediary metabolism in isolated rat-liver cells.
    Vaartjes WJ; De Haas CG; Haagsman HP
    Biochem Pharmacol; 1986 Dec; 35(23):4267-72. PubMed ID: 3790153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of inhibition of fatty acid oxidation on neonatal liver carnitine content.
    Frost SC; Wells MA
    Biochem J; 1982 Jun; 204(3):861-3. PubMed ID: 7126171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 2[5(4-chlorphenyl)pentyl]oxirane-2-carboxylate on fatty acid synthesis and fatty acid oxidation in isolated rat hepatocytes.
    Agius L; Pillay D; Alberti KG; Sherratt HS
    Biochem Pharmacol; 1985 Aug; 34(15):2651-4. PubMed ID: 2861821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma lipoproteins and regulation of hepatic metabolism of fatty acids in altered thyroid states.
    Heimberg M; Olubadewo JO; Wilcox HG
    Endocr Rev; 1985; 6(4):590-607. PubMed ID: 3908084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidation and esterification of cis- and trans-isomers of octadecenoic and octadecadienoic acids in isolated rat liver.
    Ide T; Sugano M
    Biochim Biophys Acta; 1984 Jul; 794(2):281-91. PubMed ID: 6733138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of oxidation of long-chain fatty acids to gluconeogenesis in the perfused liver of the guinea pig: effect of 2-tetradecylglycidic acid (McN-3802).
    Tutwiler GF; Brentzel HJ
    Eur J Biochem; 1982 Jun; 124(3):465-70. PubMed ID: 7106101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of hepatic triacylglycerol metabolism.
    Mayes PA
    Biochem Soc Trans; 1976; 4(4):575-80. PubMed ID: 187481
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of hepatic lipogenesis by 2-tetradecylglycidic acid.
    McCune SA; Nomura T; Harris RA
    Lipids; 1979 Oct; 14(10):880-2. PubMed ID: 502765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal responses to clofibrate in ketogenesis and triglyceride and cholesterol secretion in isolated rat liver.
    Ide T; Oku H; Sugano M
    Metabolism; 1982 Oct; 31(10):1065-72. PubMed ID: 7132732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid metabolism and lipid secretion by perfused livers from rats fed laboratory stock and sucrose-rich diets.
    Yamamoto M; Yamamoto I; Tanaka Y; Ontko JA
    J Lipid Res; 1987 Oct; 28(10):1156-65. PubMed ID: 3681140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Tetradecylglycidic acid.
    Tutwiler GF; Ho W; Mohrbacher RJ
    Methods Enzymol; 1981; 72():533-51. PubMed ID: 7311851
    [No Abstract]   [Full Text] [Related]  

  • 16. Methyl 2-tetradecylglycidate, an orally effective hypoglycemic agent that inhibits long chain fatty acid oxidation selectively.
    Tutwiler GF; Mohrbacher R; Ho W
    Diabetes; 1979 Mar; 28(3):242-8. PubMed ID: 446909
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of fatty acid oxidation and in normal and hypoxic perfused rat hearts by 2-tetradecylglycidic acid.
    Pearce FJ; Forster J; DeLeeuw G; Williamson JR; Tutwiler GF
    J Mol Cell Cardiol; 1979 Sep; 11(9):893-915. PubMed ID: 226722
    [No Abstract]   [Full Text] [Related]  

  • 18. Fatty acid metabolism and very low density lipoprotein secretion in liver slices from rats and preruminant calves.
    Graulet B; Gruffat D; Durand D; Bauchart D
    J Biochem; 1998 Dec; 124(6):1212-9. PubMed ID: 9832627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that medium-chain fatty acid oxidation can support an active gluconeogenesis in the suckling newborn rat.
    Turlan P; Ferre P; Girard JR
    Biol Neonate; 1983; 43(1-2):103-8. PubMed ID: 6850010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immediate effects of insulin and fructose on the metabolism of the perfused liver. Changes in lipoprotein secretion, fatty acid oxidation and esterification, lipogenesis and carbohydrate metabolism.
    Topping DL; Mayes PA
    Biochem J; 1972 Jan; 126(2):295-311. PubMed ID: 5071176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.